A patient has been prescribed nateglinide for the treatment of postprandial hyperglycemia. The patient should take this medication:
Explanation
•Nateglinide is a meglitinide. It stimulates insulin release from beta cells for a short time (<2 hours).
•Due to its short onset and half-life, nateglinide should be taken within 30 minutes before each meal.